20/20 GENESYSTEMS, INC.

Profile

Company Names

20/20 GENESYSTEMS, INC.

Addresses

15810 GAITHER ROAD, SUITE 235, GAITHERSBURG, MD 20877

9430 KEY WEST AVENUE, SUITE 100, ROCKVILLE, MD 20850

Phone Numbers

240-453-6339
2404536339

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$4,583,413.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2025-01-21 
$70,000.00 
$3,000,000.00 
$2,930,000.00 
Debt 
2
2016-01-28 
$2,000,000.00 
$3,000,000.00 
$1,000,000.00 
Equity 
1
2014-10-31 
$2,513,413.00 
$4,000,000.00 
$1,486,587.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JONATHAN 
 
COHEN 
EXECUTIVE OFFICER, DIRECTOR
GLOBAL SUN PARTNERS LP   |  BROOKWOOD PROGRAM MANAGEMENT, LLC   |  NEP CARPET HOLDINGS, INC.   |  20/20 GENESYSTEMS, INC.   |  JCGC MANAGEMENT 1 LLC   |  4754 ORTEGA HILLS DRIVE LLC   |  ROBOCAP PARTNERS DE I LP   |  TORO JAX HOLDINGS LLC   |  OXFORD GATE, LLC   |  TORO JAX HOLDINGS II LLC   |  TORO COLUMBUS II LLC   |  IDEALABX1, L.P.   |  TORO COLUMBUS III LLC   |  HIGH RISE CAPITAL FUND I LP   |  PARK AT BLANDING TORO EQUITY LLC   |  PLURIBUS LABS GLOBAL CORE EQUITY FUND LP   |  UNLIMITED TOMORROW, INC.   |  GOOSE CREEK DEVELOPMENT MFTH LLC   |  SURGIPOINTX SPV 1, LLC   |  NUNBELIEVABLE, INC.   |  735 RIVER ROAD PARTNERS, LLC   |  CLIMATE VAULT SOLUTIONS, INC.   |  PLATT CANYON PARTNERS LLC   |  RMWC REAL ESTATE LENDING FUND V - HYBRID EVERGREEN, LP   |  RMWC REAL ESTATE LENDING FUND V - HYBRID EVERGREEN FEEDER, LP
RICHARD 
M. 
COHEN 
DIRECTOR
HELIX BIOMEDIX INC   |  VICOR TECHNOLOGIES, INC.   |  CORMEDIX INC.   |  FULL SPECTRUM INC.   |  ZEV VENTURES INC.   |  20/20 GENESYSTEMS, INC.
JOHN 
G 
COMPTON 
DIRECTOR
20/20 GENESYSTEMS, INC.
DEAN 
 
HAUTAMAKI 
DIRECTOR
20/20 GENESYSTEMS, INC.
MICHAEL 
 
HERTZBERG 
DIRECTOR
ENVISIONIER MEDICAL TECHNOLOGIES, INC.   |  20/20 GENESYSTEMS, INC.
JOEL 
 
KANTER 
EXECUTIVE OFFICER, DIRECTOR
FIRST WAVE TECHNOLOGIES, INC.   |  DR. TATTOFF, INC.   |  MEDISYNC BIOSERVICES INC   |  WAFERGEN BIO-SYSTEMS, INC.   |  VYTERIS, INC.   |  FIRST WAVE PRODUCTS GROUP, LLC   |  MERCATOR MEDSYSTEMS INC   |  20/20 GENESYSTEMS, INC.   |  CVR MEDICAL CORP.   |  MEDITE CANCER DIAGNOSTICS, INC.   |  APPLIED UV, INC.
VLADIMIR 
 
KNEZEVIC 
DIRECTOR
20/20 GENESYSTEMS, INC.
WEI 
 
LU 
DIRECTOR
WHITE MOUNTAIN TITANIUM CORP   |  20/20 GENESYSTEMS, INC.
CAROLINE 
 
POPPER 
DIRECTOR
CLAROS DIAGNOSTICS INC   |  INNOVATIVE BIOSENSORS INC   |  NANOMR, INC.   |  RAPID PATHOGEN SCREENING INC   |  RPS DIAGNOSTICS, INC.   |  20/20 GENESYSTEMS, INC.   |  BALX HOLDINGS, LLC   |  SIDX, INC.   |  INFINITY BIO, INC.   |  PANGIA BIOTECH, INC.
PRASANTH 
 
REDDY 
DIRECTOR
20/20 GENESYSTEMS, INC.   |  GENECENTRIC THERAPEUTICS, INC.
JOHN 
W. 
ROLLINS 
DIRECTOR
AIH SUB, INC.   |  20/20 GENESYSTEMS, INC.
MICHAEL 
A 
ROSS 
DIRECTOR
CAPROCQ CORE HOLDINGS, L.P.   |  20/20 GENESYSTEMS, INC.
ANNE 
 
SHIFLETT 
EXECUTIVE OFFICER
CORRIDOR PHARMACEUTICALS, INC.   |  20/20 GENESYSTEMS, INC.
LARRY 
 
SHULMAN 
DIRECTOR
20/20 GENESYSTEMS, INC.
DONALD 
 
WALLACH 
DIRECTOR
20/20 GENESYSTEMS, INC.
JIMINY 
 
ZHOU 
EXECUTIVE OFFICER
20/20 GENESYSTEMS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-02-26
D
Link
BIOTECHNOLOGY 
SERVICES-TESTING LABORATORIES [8734] 
DECLINE TO DISCLOSE 
Debt 
2025-01-21 
2016-02-19
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-10-31 
2016-02-04
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-01-28 
2015-10-30
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-10-31 
2015-09-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-10-31 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
LBMZ SECURITIES, INC.
7874
ZACKS INVESTMENT BANK
NONE